Reports
Reports
Sale
The Germany home healthcare market was valued at USD 12.37 billion in 2023, driven by the growing burden of chronic diseases and the rising advancements in home healthcare products in the region. The market is expected to grow at a CAGR of 4.45% during the forecast period of 2024-2032, with the values likely to reach USD 18.31 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Home healthcare is the service that offers treatment while patients or individuals are at home in case of an illness or injury. It is less expensive, more convenient, and as effective as hospital care or skilled nursing facilities. The increasing elderly population and the rising burden of chronic diseases in Germany are driving the need for home-based monitoring devices and therapeutic services, which also contributes to the expansion of the global home healthcare market. The rising innovations in home healthcare products, including advanced home medical equipment and remote monitoring devices, are projected to boost the market size. Further, supportive government initiatives and the rising disposable income in Germany are likely to positively influence the market dynamics.
Growing Geriatric Population and Supportive Government Initiatives Driving the Market Growth
The rising geriatric population and the high incidence of chronic diseases in the region are contributing to the market expansion of home healthcare in Germany. The improved living standards in the country are enabling people to afford home healthcare services. The rapid growth of urban communities with small family units, limited living space, and the displacement of younger generations away from their families due to work commitments are resulting in the increased demand for home healthcare services in Germany. Additionally, the reluctance for prolonged hospital stays and the rising inclination of people to get treated in homely, social, and interactive spaces are further driving the market expansion.
The favorable government initiatives to improve healthcare services in the region are influencing the Germany home healthcare market demand. For example, in May 2021, the government of Germany agreed on a health care reform which includes an annual tax subsidy to increase the pay for nursing staff and reduce the contributions of care home residents. The government planned to contribute USD 1.22 billion annually to Germany's long-term care insurance. Over the forecast period, the development of technologically advanced home care equipment, including monitoring and diagnostic systems, and the strong presence of market players are expected to augment the market growth in the country.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current scenario in Germany. Some of the notable trends are as follows:
Key Trends | Impact |
Rising Adoption of Remote Patient Monitoring | One of the major market trends is the rising adoption of remote patient monitoring systems to monitor the health of patients in real-time with the help of digital tools. This trend facilitates the early detection of health issues and reduces emergency visits. |
Increased Use of Telehealth Services | The market is witnessing an increasing use of telehealth services, particularly following the COVID-19 pandemic, which has impacted the market growth. Telehealth reduces the need for physical visits to the healthcare provider by offering virtual consultations and follow-ups. |
Growing Adoption of Homecare Software Solutions | The Germany home healthcare market share is impacted by the increased utilization of software solutions for scheduling appointments, billing, and patient management by homecare providers. Advancements in homecare software solutions are anticipated to elevate the market value. |
Increased Investment in the Home Healthcare Sector | The market is experiencing a significant increase in investments and mergers and acquisitions within the home healthcare sector. As more and more companies invest in home healthcare products and services to expand service offerings and market presence, the market share in Germany is poised to grow in the coming years. |
Market Breakup by Product
Market Breakup by Application
Market Segmentation Based on Application Areas is Anticipated to Witness Substantial Growth
Based on the application, the market is segmented into cancer, respiratory disease, mobility disorders, cardiovascular diseases (CVD) & hypertension, pregnancy, wound care, diabetes, and hearing disorders, among others. The diabetes segment represents a significant market share, owing to the increasing prevalence of diabetes. It is estimated that 8.5 million are living with diabetes in Germany, with around 2 million having undiagnosed diabetes. The rising number of diabetes cases is fuelling the demand for home healthcare solutions such as continuous glucose monitoring systems, insulin pumps, and telemedicine services, which are poised to aid market growth. Further, advancements in diabetes management technologies are expected to boost the market share in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The home healthcare market in Germany is witnessing significant growth across all regions, driven by the growing aging population and rising disposable incomes which fuels the demand for home-based healthcare solutions to manage medical conditions. In Northern Germany, with major markets in Hamburg and Bremen, the presence of a well-established healthcare system and the growing adoption of healthcare technologies and services supports market expansion. Eastern Germany also holds a high market value, with cities like Berlin and Leipzig covering significant market share. The rising investment in healthcare infrastructure and the increased government initiatives promoting home healthcare are major trends in the region bolstering market growth.
The key features of the market report comprise patent analysis and strategic initiatives by the leading key players. The major companies in the market are as follows:
Becton, Dickinson and Company
American multinational medical technology company Becton, Dickinson and Company (BD) is a prominent player in the market known for its wide range of medical supplies and diagnostic products. In the home healthcare segment, the company offers CME Ambulatory pumps and CME Ambulatory Infusion Systems to address various clinical requirements at home.
Fresenius Medical Care
German-based Fresenius Medical Care is a leading provider of dialysis products and services. The company offers high-quality home hemodialysis and peritoneal dialysis products and contributes significantly to the Germany home healthcare market growth.
Medtronic plc
Headquartered in Ireland, Medtronic plc offers a diverse range of therapeutic and diagnostic medical products. The medical device company is known for its cardiovascular monitoring and remote patient monitoring systems which are designed to manage various health conditions at home.
3M Company
United States-based 3M Company is a multinational conglomerate that operates in the healthcare sector, among others. It is one of the leading players in the market known for its extensive distribution network and focus on providing reliable and effective home healthcare solutions.
Other key players in the market include Abbott Laboratories, B Braun Melsungen AG, Arkray, Inc., F Hoffmann La Roche AG, GE HealthCare, Koninklijke Philips N.V., Nui Care GmbH, and INTU Diagnostics GmBH.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Home Healthcare Market Overview
3.1 Europe Home Healthcare Market
3.1.1 Europe Home Healthcare Market Historical Value (2017-2023)
3.1.2 Europe Home Healthcare Market Forecast Value (2024-2032)
3.2 Germany Home Healthcare Market
3.2.1 Germany Home Healthcare Market Historical Value (2017-2023)
3.2.2 Germany Home Healthcare Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Germany Home Healthcare Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter’s Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Germany Home Healthcare Market, Epidemiology Snapshot
6.1 Overview of Germany Home Healthcare Incidence Number (2017-2032)
6.2 Incidence Number, By Indication (2017-2032)
6.2.1 Cancer
6.2.2 Respiratory Disease
6.2.3 Mobility Disorders
6.2.4 CVD & Hypertension
6.2.5 Wound Care
6.2.6 Diabetes
6.2.7 Hearing Disorders
6.2.8 Others
7 Germany Home Healthcare Market Segmentation (2017-2032)
7.1 Germany Home Healthcare Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Products
7.1.2.1 Therapeutic Products
7.1.2.1.1 Dialysis Equipment
7.1.2.1.2 Wound Care Products
7.1.2.1.3 IV Equipment
7.1.2.1.4 Sleep Apnea Therapeutic Devices
7.1.2.1.5 Insulin Delivery Devices
7.1.2.1.6 Oxygen Delivery Systems
7.1.2.1.7 Inhalers
7.1.2.1.8 Ventilators
7.1.2.1.9 Clinical Nutrition
7.1.2.1.10 Others
7.1.2.2 Diagnostic & Monitoring Products
7.1.2.2.1 Blood Glucose Monitors
7.1.2.2.2 Blood Pressure Monitors
7.1.2.2.3 Temperature Monitoring Device
7.1.2.2.4 Ovulation & Pregnancy Test Kits
7.1.2.2.5 Pulse Oximeters
7.1.2.2.6 Drug and Alcohol Test Kits
7.1.2.2.7 Home Sleep Testing Devices
7.1.2.2.8 Cholesterol Testing Products
7.1.2.2.9 ECG Devices
7.1.2.2.10 Home Hemoglobin A1C Test Kits
7.1.2.2.11 Others
7.1.2.3 Mobility Care Products
7.1.2.3.1 Wheelchair
7.1.2.3.2 Mobility Scooters
7.1.2.3.3 Walkers and Rollators
7.1.2.3.4 Crutches
7.1.2.3.5 Others
7.1.3 Services
7.1.3.1 Skilled Home Healthcare Services
7.1.3.1.1 Physician Primary Care
7.1.3.1.2 Nursing Care
7.1.3.1.3 Physical/Occupational/Speech therapy
7.1.3.1.4 Hospice and Palliative Care
7.1.3.1.5 Others
7.1.3.2 Unskilled Home Healthcare Services
7.2 Germany Home Healthcare Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Cancer
7.2.3 Respiratory Disease
7.2.4 Mobility Disorders
7.2.5 CVD & Hypertension
7.2.6 Pregnancy
7.2.7 Wound Care
7.2.8 Diabetes
7.2.9 Hearing Disorders
7.2.10 Others
8 Regulatory Framework
9 Patent Analysis
9.1 Analysis by Type of Patent
9.2 Analysis by Publication Year
9.3 Analysis by Issuing Authority
9.4 Analysis by Patent Age
9.5 Analysis by CPC Analysis
9.6 Analysis by Patent Valuation
9.7 Analysis by Key Players
10 Strategic Initiatives
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership and Collaborations
10.3 Analysis by Joint Ventures
10.4 Analysis by Leading Players
10.5 Analysis by Geography
11 Supplier Landscape**
11.1 Market Share Analysis (Top 5 Companies)
11.2 Becton, Dickinson and Company
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Fresenius Medical Care
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Medtronic plc
11.4.1 Financial Analysis
11.4.2 Product Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 3M Company
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Abbott Laboratories
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 B Braun Melsungen AG
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Arkray, Inc.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 F Hoffmann La Roche AG
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 GE HealthCare
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 Koninklijke Philips N.V.
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Nui Care GmbH
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 INTU Diagnostics GmBH
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
12 Germany Home Healthcare Market – Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements and not included in the standard report.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.